Poland, March 24 -- Poland based ASTELLAS PHARMA sp. z o. o. has secured contract from Instytut "Centrum Zdrowia Matki Polki" for Pharmaceutical products - SZP281132026 - Delivery of a medicinal product containing the active substance - enfortumab vedotin for the CZMP Institute. The value of the contract is worth 23636572 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....